Discover and read the best of Twitter Threads about #Biocon
Most recents (15)
#Biocon Q3 FY22 concall highlights 🧬
Like & Retweet For better Reach !
Key highlights:
1.Featured in DJSI for Emerging markets. Received total sustainability score of 45 against industry average of 18 (93rd percentile).
Like & Retweet For better Reach !
Key highlights:
1.Featured in DJSI for Emerging markets. Received total sustainability score of 45 against industry average of 18 (93rd percentile).
2.Received Carbon Disclosure Project(CDP) rating upgrade from C to B.
3. Selected to participate in PLI Scheme 2.0 for Pharmaceuticals. They will receive financial incentives of ₹250 Cr over 6 years.
3. Selected to participate in PLI Scheme 2.0 for Pharmaceuticals. They will receive financial incentives of ₹250 Cr over 6 years.
New Management Hires:
1.Appointed Matthew Erick as the Chief Commercial Officer - Advanced Markets for Biocon Biologics. He has over 2 decades of experience in the Healthcare Sector in the US. He was appointed to set up commercial capabilities in advanced markets of
1.Appointed Matthew Erick as the Chief Commercial Officer - Advanced Markets for Biocon Biologics. He has over 2 decades of experience in the Healthcare Sector in the US. He was appointed to set up commercial capabilities in advanced markets of
🌟Looking forward to #MuhuratTrading?
🙌Check out this thread to see what #Trinkerr Experts chose as their top #DIWALIPICKS! ✨
#StockMarket #stocks
🙌Check out this thread to see what #Trinkerr Experts chose as their top #DIWALIPICKS! ✨
#StockMarket #stocks
✨@MoneyMystery's #DIWALIPICKS for #MuhuratTrading🎁
🌟#InoxLeisure
💫Checkout his complete #Trinkerr portfolio: trin.kr/RwuX
🌟#InoxLeisure
💫Checkout his complete #Trinkerr portfolio: trin.kr/RwuX
✨ @MarketScientist's #DIWALIPICKS for #MuhuratTrading🎁
🌟#ACE
🌟#Borosil
🌟#JBMGroup
🌟#GNFC
🌟#westlife
🌟#AssociatedBreweries
💫Checkout his complete #Trinkerr portfolio: trin.kr/pwiC
🌟#ACE
🌟#Borosil
🌟#JBMGroup
🌟#GNFC
🌟#westlife
🌟#AssociatedBreweries
💫Checkout his complete #Trinkerr portfolio: trin.kr/pwiC
33) Prices have a memory, take advantage of it.
34) Be prepared as the stock prepares itself, this must be in realtime.
A selection of stock here explains how it happened live using #NimblrTA #Realtime #Dashboard at kkonline.org/nimblrta/
A selection of stock here explains how it happened live using #NimblrTA #Realtime #Dashboard at kkonline.org/nimblrta/
35) Be with what is buzzing, be with the flow, know such stocks easily and wait for the right entry.
Not everyone has the resources to enter Biosimilar markets
The science of #Biocon remains unseen, esp. by CSLA analysts.
The science of #Biocon remains unseen, esp. by CSLA analysts.
A biologic compared to a generic drug.
1 new chart everyday, it could be from any space ~ equities / commodities / crypto / forex / bonds , etc
Will try to do it daily 🙏💪
Here's the first one 👇
SBI vs BankNifty
Ratio chart has given monthly breakout implying SBI could outperform BN in coming months.
#PB365
Will try to do it daily 🙏💪
Here's the first one 👇
SBI vs BankNifty
Ratio chart has given monthly breakout implying SBI could outperform BN in coming months.
#PB365
Below are few gems in #Indianpharma space…I own #Lauruslabs #Suvenpharma and #Suvenlife..
#Suvenpharma – NCE CRAMS – top end segment in CRAMs
#Suvenlife – Pure play CNS R&D – CNS is most difficult but largest market share in pharma
#Lauruslabs – process Innovation
1/3
#Suvenpharma – NCE CRAMS – top end segment in CRAMs
#Suvenlife – Pure play CNS R&D – CNS is most difficult but largest market share in pharma
#Lauruslabs – process Innovation
1/3
Stocks for 24/09/20 Intraday
Based on NR7:
#KOTAKBANK
#GLENMARK
#BIOCON
#TITAN
#ICICIPRULI
Based on NR4:
#BANDHANBNK
#HDFCBANK
#CIPLA
#GRANULES
#CADILAHC
Including NR4 too to increase my options for tomorrow
Based on NR7:
#KOTAKBANK
#GLENMARK
#BIOCON
#TITAN
#ICICIPRULI
Based on NR4:
#BANDHANBNK
#HDFCBANK
#CIPLA
#GRANULES
#CADILAHC
Including NR4 too to increase my options for tomorrow
Some of you asked what I meant by "Volatility Concept"
while selecting stocks
Basically, you don't want stocks which are not moving organically, doing pump/dump, staying flat, or forming too many gaps
These were NR7 stocks which I rejected because of above reasons:
while selecting stocks
Basically, you don't want stocks which are not moving organically, doing pump/dump, staying flat, or forming too many gaps
These were NR7 stocks which I rejected because of above reasons:
Results of the Day: 4/10 Stocks gave tradeable moves
A tricky, no easy setups day today
1/4 : #KOTAKBANK : PROFIT : +1.7R
As posted earlier:
It gave a loss of -1R, followed by another signal giving +2R
A tricky, no easy setups day today
1/4 : #KOTAKBANK : PROFIT : +1.7R
As posted earlier:
It gave a loss of -1R, followed by another signal giving +2R
Continuing the Exercise, time for the weekly review of this:
Stocks which were at 5 Low:
1. #BIOCON : Swept equal lows, good bounce
2. #JKTYRE : Back at Support
3. #HINDUNILVR : Broken previous Support
4. #GODREJPROP : Good bounce, at Equal highs
Stocks which were at 5 Low:
1. #BIOCON : Swept equal lows, good bounce
2. #JKTYRE : Back at Support
3. #HINDUNILVR : Broken previous Support
4. #GODREJPROP : Good bounce, at Equal highs
Stocks which were at 13 Week High:
1. #SBIN : Testing broken resistance
2. #LICHSGFIN : Testing broken resistance
3. #DCBBANK : Testing broken resistance
4. #CHOLAFIN : Testing broken resistance
1. #SBIN : Testing broken resistance
2. #LICHSGFIN : Testing broken resistance
3. #DCBBANK : Testing broken resistance
4. #CHOLAFIN : Testing broken resistance
Continued..
5. #TATACHEM : Broke ATH BUT back down
6. #NOCIL : Tested Support
7. #MFSL : Consolidating at Resistance
8. #BAJFINANCE : Looking Good, tested broken Resistance
5. #TATACHEM : Broke ATH BUT back down
6. #NOCIL : Tested Support
7. #MFSL : Consolidating at Resistance
8. #BAJFINANCE : Looking Good, tested broken Resistance
A Very useful Exercise for Positional/Swing Trading, Suggested by @ST_PYI (Raunak Sir)
Stocks I am watching for this week are
At 5 week Low (No Stock is at 13 week Low):
1.#BIOCON
2.#JKTYRE
3.#HINDUNILVR
4.#GODREJPROP
Screener: chartink.com/screener/5-wee…
Stocks I am watching for this week are
At 5 week Low (No Stock is at 13 week Low):
1.#BIOCON
2.#JKTYRE
3.#HINDUNILVR
4.#GODREJPROP
Screener: chartink.com/screener/5-wee…
Stocks at 13 week high:
1. #SBIN
2. #LICHSGFIN
3. #DCBBANK
4. #CHOLAFIN
Screener : chartink.com/screener/13-we…
1. #SBIN
2. #LICHSGFIN
3. #DCBBANK
4. #CHOLAFIN
Screener : chartink.com/screener/13-we…
Stocks for 24/08/20 Intraday
#RBLBANK
#CHOLAFIN
#INDUSINDBK
#CIPLA
#TECHM
#AUROPHARMA
#McDOWELL_N
#BIOCON
#SRTRANSFIN
#CUMMINSIND
Based on NR7, Volatility and Volume concepts
#RBLBANK
#CHOLAFIN
#INDUSINDBK
#CIPLA
#TECHM
#AUROPHARMA
#McDOWELL_N
#BIOCON
#SRTRANSFIN
#CUMMINSIND
Based on NR7, Volatility and Volume concepts
Results of the Day : 6/10 stocks gave tradeable moves
1/6 : #CHOLAFIN : LOSS : -1R
Price came up to previous session resistance and formed a Bearish engulfing candle with wick.
All conditions for my setup were met and hence Short trade was taken.
1/6 : #CHOLAFIN : LOSS : -1R
Price came up to previous session resistance and formed a Bearish engulfing candle with wick.
All conditions for my setup were met and hence Short trade was taken.
2/6 : #CIPLA : LOSS : -0.2R
Price broke a significant support with Volumes.
Short trade was closed early since Bullish tail forming candle came in with Good Volumes
Price broke a significant support with Volumes.
Short trade was closed early since Bullish tail forming candle came in with Good Volumes
#Bollingerbands (Threads to understand & It's actual use)
( Practical use)
*We all know that #BB is give us volatility of stock.
* It works on standard deviation principle
* Price always wave between Upper and Lower band.
( Practical use)
*We all know that #BB is give us volatility of stock.
* It works on standard deviation principle
* Price always wave between Upper and Lower band.
* It is always said that use #volatility contraction .
*After Volatility contraction price , move in quicker way.
* To identify this #volatility contraction, we use #BB
Examples show that round is volatility contraction. Price stuck in range and volatility is cooled off.
*After Volatility contraction price , move in quicker way.
* To identify this #volatility contraction, we use #BB
Examples show that round is volatility contraction. Price stuck in range and volatility is cooled off.
but , how to identify that volatility is really contracted?
many false signal will be generated.
So here is the secret.
Dont just trap in just #Bollingerbands
I am sharing secret to use it with #ketlner Channel
many false signal will be generated.
So here is the secret.
Dont just trap in just #Bollingerbands
I am sharing secret to use it with #ketlner Channel
Stocks for 07/08/20 Intraday
#AXISBANK
#HDFCBANK
#HDFC
#BIOCON
#HDFCLIFE
#GRASIM
#DABUR
#PEL
#TATACHEM
#GODREJCP
Based on NR7, Volume and Volatility
#AXISBANK
#HDFCBANK
#HDFC
#BIOCON
#HDFCLIFE
#GRASIM
#DABUR
#PEL
#TATACHEM
#GODREJCP
Based on NR7, Volume and Volatility
Only 1 stock gave tradeable move today!
It was #HDFCBANK. However, it gave two separate entries.
1/2 Entry was @ 11:30, price made huge tails at Support with High Volume and was consolidating on VWAP.
+2R profits booked till the previous day resistance level
It was #HDFCBANK. However, it gave two separate entries.
1/2 Entry was @ 11:30, price made huge tails at Support with High Volume and was consolidating on VWAP.
+2R profits booked till the previous day resistance level
2/2 Entry in #HDFCBANK was @ 01:25. A/D ratio was around 2:1 the entire day and hence supported Bullish bias. The price was again consolidating at Previous day support turned Resistance turned Support!
Entry was with BE candle. +1.5R profits booked for this second, late trade.
Entry was with BE candle. +1.5R profits booked for this second, late trade.
A tweet thread.
There are a few noteworthy drawbacks in India's education system: One is the emphasis on fact rather than method/process in science education explained in this article: newslaundry.com/2020/07/06/ind…)
There are a few noteworthy drawbacks in India's education system: One is the emphasis on fact rather than method/process in science education explained in this article: newslaundry.com/2020/07/06/ind…)
Another is the artificial separation of the arts and the sciences. So we end up with engineers and scientists (who anyway lack the rigour and scepticism of science) without an understanding of the social sciences of behavioural psychology, economics, philosophy or literature
Equally we have arts graduates with limited understanding of science or biology, and even less about scientific method and scepticism. Of course those who never get to school or do not progress beyond primary school are left behind altogether.
A tweet thread.
Subject: Critical appraisal of Itolizumab in #Coronavirus infection.
Events: 1. @sardesairajdeep ran a programme on 11 July showcasing what was claimed to be a breakthrough in the hunt for a drug that worked against #Covid19. Featured #Biocon's @Kiranshaw
Subject: Critical appraisal of Itolizumab in #Coronavirus infection.
Events: 1. @sardesairajdeep ran a programme on 11 July showcasing what was claimed to be a breakthrough in the hunt for a drug that worked against #Covid19. Featured #Biocon's @Kiranshaw
Kiran Mazumdar-Shaw has blocked me so she won't see this thread. You can watch @sardesairajdeep programme here: .
Essentially it explained the #cytokinestorm that happens is some patients with #Covid19 and can be fatal. #Itolizumab counters this.
Essentially it explained the #cytokinestorm that happens is some patients with #Covid19 and can be fatal. #Itolizumab counters this.
What is Itolizumab? Here is it's Wikipedia entry: It is a relatively newly developed drug in a class of drugs known as monoclonal antibodies (all of them end in '-mab'). They have been around as a class of pharmacologic agent since 1986.
BIOCON
Q4FY20 - Muted growth of 6%,revenue 1644cr ,one time covid impact on Biologics business
Full year ,strong performance, biologics grew 29%,small molecules 18% ,research 10%.
Biologics to recover inQ1 & normalize in Q2
@kiranshaw @Bioconlimited #biosimilars
Q4FY20 - Muted growth of 6%,revenue 1644cr ,one time covid impact on Biologics business
Full year ,strong performance, biologics grew 29%,small molecules 18% ,research 10%.
Biologics to recover inQ1 & normalize in Q2
@kiranshaw @Bioconlimited #biosimilars
Pegfilgrastim,Fulphila commercialized in Australia & Canada
USFDA accepted license application for Bevacizumab
Insulin facility in Malaysia received EIR from USFDA
Indian govt allowed to test Itolizumab in mod to severe Covid ,initial result appear promisin
#COVID19 #biocon
USFDA accepted license application for Bevacizumab
Insulin facility in Malaysia received EIR from USFDA
Indian govt allowed to test Itolizumab in mod to severe Covid ,initial result appear promisin
#COVID19 #biocon
Expect US launch of Insulin Glargine( Semglee) in midCY20 .
Ogivri & Semglee(Insulin Glargine) commercialized in Australia earlier this financial year
Ogivri & Semglee(Insulin Glargine) commercialized in Australia earlier this financial year
